Papers
Google Scholar | ORCID | *Corresponding author
2026
Shi, B. X., Tsai, D. J., Lin, C., Lin, S. H., Hsieh, P. H.*, & Fang, W. H.* (2026). Cost-Utility Analysis of Deep Learning-Based Opportunistic Osteoporosis Screening Using Chest Radiographs: Implications of Diagnostic Thresholds and Confirmatory Testing. Archives of Osteoporosis. (in press)
Fang, C. Y., Lin, T. K., Yang, F. C., Liu, Y., Ruan, Y. Z., & Hsieh, P. H.* (2026). Economic evaluation of atogepant compared to placebo for the preventive treatment of episodic migraine in Taiwan. BMC Health Services Research. (in press)
2025
Chan, C. S., Huang, T. Y., Tseng, W. H., Lin, T. K., Yang, F. C., ... & Hsieh, P. H.* (2025). Cost-Utility Analysis of Eptinezumab for Migraine Prevention in Taiwan. Health Economics Review.
Wu, W. T., Chao, Y. W., Lin, T. K., Huang, C. K., & Hsieh, P. H.* (2025). Economic evaluation of AI-assisted technologies in healthcare: A systematic review. Journal of Food and Drug Analysis, 33(4), 487-500.
Grieve, E., Deidda, M., Krauth, S. J., Biswaro, S. M., Halliday, J. E., Hsieh, P. H., ... & McIntosh, E. (2025). How do musculoskeletal disorders impact on quality of life in Tanzania? Results from a community-based survey. BMJ Open, 15(12), e092877.
Liu, W. T., Lin, C. S., Lin, C., Lin, T. K., Lin, W. Y., Lee, C. C., ... & Hsieh, P. H.* (2025). Universal Atrial Fibrillation Screening Using Electrocardiographic Artificial Intelligence: A Cost-Effective Approach in Rural Communities. Journal of Medical Systems, 49(1), 145.
Hsieh, P. H., Lin, C., Lin, C. S., Liu, W. T., Lin, T. K., Tsai, D. J., ... & Tsai, C. S. (2025). Economic analysis of an AI-enabled ECG alert system: impact on mortality outcomes from a pragmatic randomized trial. npj Digital Medicine, 8(1), 1-7.
Tsai, D. J., Lin, C., Liu, W. T., Lee, C. C., Chang, C. H., Lin, W. Y., ... & Lin, C. S. (2025). Artificial intelligence-assisted diagnosis and prognostication in low ejection fraction using electrocardiograms in inpatient department: a pragmatic randomized controlled trial. BMC Medicine, 23(1), 1-12.
Hsieh, P. H., Shi, B. X., Lai, C. Y., Chen, Y. C., Lin, C., Wu, O., ... & Tsai, S. H. (2025). Economic impact of patients with medical evacuation in remote islands: a case study in Matsu Islands. Frontiers in Public Health, 13, 1542172.
Chen, W. T., Chao, T. Y., Huang, W. Z., Hsu, C. W., Tseng, P. T., Tzeng, N. S., ... & Chen, T. Y. (2025). Effectiveness of Emotional Freedom Techniques in Alleviating Symptoms Associated with Posttraumatic Stress Disorder: A Systematic Review and Meta-analysis. European Archives of Psychiatry and Clinical Neuroscience, 1-11.
Deidda, M., Grieve, E., Krauth, S., Hsieh, P. H., Yongolo, N., Siebert, S., ... & McIntosh, E. (2025). Economic burden of musculoskeletal disorders in Tanzania: results from a community-based survey. BMJ Open, 15(1), e087425.
2024
Liu, W. T., Hsieh, P. H., Lin, C. S., Fang, W. H., Wang, C. H., Tsai, C. S., ... & Tsai, D. J. (2024). Opportunistic screening for asymptomatic left ventricular dysfunction with the use of electrocardiographic artificial intelligence: a cost-effectiveness approach. Canadian Journal of Cardiology, 40(7), 1310-1321.
2022
Hsieh P-H*, Geue C , Wu O, McIntosh E, Siebert S. (2022). How do multiple long-term conditions impact on the cost-of-illness in early rheumatoid arthritis?. RMD Open, 8(2), e002454.
2021
Quinn T*, Burton J, Carter B, Cooper C, Dwan K, Field R, Freeman S, Geue C, Hsieh P-H, McGill K, Nevill C, Rana D, Sutton A, Taylor-Rowan M, Xin X (2021). Following the Science? Comparison of methodological and reporting quality of COVID-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 1-10.
2020
Hsieh P-H*, Wu O, Geue C, McIntosh E, McInnes IB, Siebert S (2020). Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era. Annals of the Rheumatic Diseases, 79(6), 771-777.
Presentations
2026
Cost-Effectiveness of Vadadustat for the Treatment of Renal Anemia in Adult Hemodialysis Patients: A Healthcare Perspective. International Society for Pharmacoepidemiology Annual Meeting, Milan, Italy, August 2026.
Cost-Utility Analysis of Luspatercept versus Epoetin Alfa for Anemia in Lower-Risk Myelodysplastic Syndromes. International Society for Pharmacoepidemiology Annual Meeting, Milan, Italy, August 2026.
Economic Evaluation of Bispecific T-Cell Engager Antibodies and CAR T-Cell Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma. Health Technology Assessment International Annual Meeting, Istanbul, Turkey, June 2026. (oral presentation)
Economic Impact of an AI-Enabled ECG Alert for Identifying ST-Elevation Myocardial Infarction: Analysis from a Pragmatic Randomized Trial. Health Technology Assessment International Annual Meeting, Istanbul, Turkey, June 2026.
Cost-Effectiveness Of Dapagliflozin for Elderly Patients with Chronic Kidney Disease in Taiwan. Health Technology Assessment International Annual Meeting, Istanbul, Turkey, June 2026.
2025
Efficacy and Safety of Nalbuphine Comparing With Analgesics for Moderate to Severe Postoperative Pain: A Systematic Review and Network Meta-Analysis. International Society for Pharmacoeconomics and Outcomes Research Europe Conference, Glasgow, UK, November 2025. (Selected as top 5% finalist and poster tour)
Economic Evaluation of Atogepant Versus Placebo for the Preventive Treatment of Episodic Migraine in Taiwan. International Society for Pharmacoeconomics and Outcomes Research Europe Conference, Glasgow, UK, November 2025.
Cost-Utility Analysis of AI-Assisted Ultrasound for Breast Cancer Detection in Taiwan. International Society for Pharmacoeconomics and Outcomes Research Europe Conference, Glasgow, UK, November 2025.
Comparison of Bispecific T-Cell Engager Antibodies and CAR-T Therapies for Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma: A Systematic Review and Meta-Analysis. International Society for Pharmacoeconomics and Outcomes Research Europe Conference, Glasgow, UK, November 2025.
Economic Analysis of an AI-Enabled ECG Alert System: Impact on Mortality Outcomes from a Pragmatic Randomized Trial. HTAsiaLink Conference 2025. Singapore, August 2025.
2024 and before
Cost-Effectiveness of Eptinezumab for Preventing Migraines. International Society for Pharmacoeconomics and Outcomes Research Europe Conference, Barcelona, Spain, November 2024. (Selected as top 5% finalist)
Comparison of Conventional Chemotherapy Regimens in Adults with Acute Lymphoblastic Leukemia: A Systematic Review and Pooled Survival Analysis. International Society for Pharmacoeconomics and Outcomes Research Europe Conference, Barcelona, Spain, November 2024.
Comparison of Targeted Therapy in Adult Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia (Ph+ B-ALL), International Society for Pharmacoeconomics and Outcomes Research Europe Conference, Barcelona, Spain, November 2024.
Cost-effectiveness Analysis of Universal Screening for Atrial Fibrillation Using Electrocardiographic Artificial Intelligence in a Rural Community in Taiwan, Philadelphia, USA, November 2023. (selected for a Moderated Poster presentation)
Estimating the quality of life and economic impact of arthritis in Tanzania. International Health Economics Association, Cape town, South Africa, July 2023.
Estimating the Quality-of-Life Impact of Musculoskeletal Disorders in Tanzania: Results from a Cross-Sectional Community-Based Survey. International Health Economics Association, Cape town, South Africa, July 2023.
Estimating the quality of life and economic impact of arthritis in Tanzania. British Society for Rheumatology, Glasgow, UK, April 2022.
How Does Multimorbidity Impact on the Cost-of-Illness in Patients with Rheumatoid Arthritis? Results from the SERA study. Health Technology Assessment International Annual Meeting, Manchester, UK, June 2021. (shortlisted for the best student oral presentation award)
How does multimorbidity impact on the direct and indirect costs in patients with rheumatoid arthritis? European Alliance of Associations for Rheumatology Congress, Paris, France, June 2021.
Impact on Costs in Patients with early Rheumatoid Arthritis. International Society for Pharmacoeconomics and Outcomes Research Asia Pacific Virtual Conference. September 2020.
Impact of Biologics on Rheumatoid Arthritis: How Have Costs Evolved? Health Technology Assessment International Annual Meeting, Cologne, Germany, June 2019.
The Evolving Cost of Illness of Rheumatoid Arthritis: A Systematic Review. International Society for Pharmacoeconomics and Outcomes Research Asia Pacific Congress, Tokyo, Japan, September 2018.
The Evolving Drug Expenses and Healthcare Costs of Rheumatoid Arthritis: A Systematic Review. Poster presentation. International Pharmaceutical Federation (FIP) World Congress, Glasgow, UK, September 2018.
Ping-Hsuan Hsieh (Shawn), PhD
pinghsuan.h@mail.ndmutsgh.edu.tw
School of Pharmacy, College of Pharmacy, National Defense Medical University
9F, No. 161, Sec. 6, Minquan E. Rd., Neihu Dist., Taipei 11490, Taiwan